From Biomedical Datasets to Fairness-Aware Recommendations: An Integrated Data Orchestration Pipeline for Binary Clinical Predictions
Abstract: Many problems in biomedicine can be posed as binary classification. When they are addressed using artificial intelligence methods, though, average performance alone does not show whether a dataset is artificial intelligence ready, whether the endpoint is clinically valid, or whether errors are unevenly distributed across patient subgroups. This article presents the Fairness-Aware Data Orchestration Pipeline (FADOP), a reusable workflow that analyzes biomedical datasets, trains baseline binary classifiers, audits…
Hospital Universitari Doctor Peset, València 09 by 19Tarrestnom65. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0
Many problems in biomedicine can be posed as binary classification. When they are addressed using artificial intelligence methods, though, average performance alone does not show whether a dataset is artificial intelligence ready, whether the endpoint is clinically valid, or whether errors are unevenly distributed across patient subgroups.
This article presents the Fairness-Aware Data Orchestration Pipeline (FADOP), a reusable workflow that analyzes biomedical datasets, trains baseline binary classifiers, audits subgroup error patterns, tests mitigation strategies, and generates a documented recommendation. Such a pipeline is intended for systematic evaluation before clinical translation, not as an automatic deployment tool.
- Many problems in biomedicine can be posed as binary classification.
- This article presents the Fairness-Aware Data Orchestration Pipeline (FADOP), a reusable workflow that analyzes biomedical datasets, trains baseline binary classifiers, audits subgroup error patterns, tests mitigation strategies, and generates a documented recommendation.
- Such a pipeline is intended for systematic evaluation before clinical translation, not as an automatic deployment tool.
When they are addressed using artificial intelligence methods, though, average performance alone does not show whether a dataset is artificial intelligence ready, whether the endpoint is clinically valid, or whether errors are unevenly distributed across patient subgroups.
Sources
- Peer-reviewedComputational and Structural Biotechnology Journal2026-09-03
How should this claim be treated?
ace
The debate